Zymeworks BC Inc

Zymeworks BC Inc

ZYME

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.93B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-13--135%-0.4
$39.80

Target Price by Analysts

48.2% upsideZymeworks BC Target Price DetailsTarget Price
$-17.73

Current Fair Value

166.1% downside

Overvalued by 166.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.93 Billion
Enterprise Value$-144,994,419,657.00
Dividend Yield$- (-)
Earnings per Share$-1.08
Beta1.19
Outstanding Shares72,993,313

Return

Return on Equity-135.41%ROE
Return on Assets-27.41%
Return on Invested Capital-31.87%

Valuation & Multiples

P/E Ratio-12.99P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.02Price to Book Ratio
Enterprise Value to Revenue-57651.86
Enterprise Value to EBIT1.3
Enterprise Value to Net Income1
Total Debt to Enterprise-0.22
Debt to Equity0.4Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.57
Average shareholder expectation
Revenue Estimate
$4.54 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.42
Average shareholder expectation
Revenue Estimate
$231.87 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5137▲ 38.65%
Total Calls182,600▼ 58.96%
Total Puts93,800▲ 65.72%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %93.87%▼ 0.27%
Total Invested$1.79B▲ 1.69%
Investors Holding208▼ 14.00%

ESG Score

No data

About Zymeworks Inc

CEO: Ali Tehrani